New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
BioMarin Pharmaceutical Inc.
BMRN
Shape
US Flag

NASDAQ

13B

Biotechnology

Next Earning date - 29 Oct 2024

13B

Biotechnology

Next Earning date - 29 Oct 2024

69.73USD
Shape-0.66 ( -0.94%)
favorite-chart

Relative Strenght

21
favorite-chart

Volume Buzz

-41%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

30%

Quote Panel

Shape
Updated October 27, 2024
1W -0.78 % 1M -0.80 % 3M -17.06 % 1Y -13.89 %

Key Metrics

Shape
  • Market Cap

    13.28B


  • Shares Outstanding

    190.38M


  • Share in Float

    187.97M


  • Dividende

    0


  • Earning Date

    29 Oct 2024


  • Price Target

    69.73


  • Average Volume

    1.74M


  • Beta

    0.306


  • Range

    67.75-99.56


  • Industry

    Biotechnology


  • Website

    https://www.biomarin.com


  • Sector

    Healthcare


Fundamentals

Shape

26.61x

P/E Ratio

5.13x

P/S Ratio

2.51x

P/B Ratio

0.2

Debt/Equity

9.9%

Net Margin

$1.3

EPS

How BMRN compares to sector?

P/E Ratio

Relative Strength

Shape

BMRN

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$3B

Shape337%

2025-Revenue

$3.01

Shape437%

2025-EPS

$120M

Shape-8%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Bernstein

upgrade

Previous: Market Perform

2024-08-20

Now: Outperform

Evercore ISI

initialise

Previous: Not converted

2024-05-13

Now: Outperform

Bernstein

upgrade

Previous: Not converted

2023-10-23

Now: Market Perform

Raymond James

initialise

Previous: Not converted

2023-09-28

Now: Market Perform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+150%

0.45
vs 0.18

Q4.22

arrow
arrow

+1100%

0.36
vs 0.03

Q1.23

arrow
arrow

+9%

0.6
vs 0.55

Q2.23

arrow
arrow

-8%

0.54
vs 0.59

Q3.23

arrow
arrow

+2%

0.46
vs 0.45

Q4.23

arrow
arrow

+36%

0.49
vs 0.36

Q1.24

arrow
arrow

+18%

0.71
vs 0.6

Q2.24

arrow
arrow

+78%

0.96
vs 0.54

Q3.24

arrow
arrow

+15%

0.53
vs 0.46

Q4.24

arrow
arrow

+20%

0.59
vs 0.49

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+24%

505.3M  vs 408.7M

Q4.22

arrow
arrow

+20%

537.5M  vs 449.8M

Q1.23

arrow
arrow

+14%

592.9M  vs 519.4M

Q2.23

arrow
arrow

+11%

594.6M  vs 533.8M

Q3.23

arrow
arrow

+16%

586M  vs 505.3M

Q4.23

arrow
arrow

+20%

646.2M  vs 537.5M

Q1.24

arrow
arrow

+9%

648.8M  vs 592.9M

Q2.24

arrow
arrow

+19%

708.7M  vs 594.6M

Q3.24

arrow
arrow

+20%

702.5M  vs 586M

Q4.24

arrow
arrow

+14%

735.1M  vs 646.2M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

0%

-0.00
vs 0.01

Q4.22

arrow
arrow

0%

-0.00
vs -0.00

Q1.23

arrow
arrow

+1%

0.01
vs -0.00

Q2.23

arrow
arrow

+1%

0.01
vs 0.01

Q3.23

arrow
arrow

+1%

0.01
vs 0.01

Q4.23

arrow
arrow

+0%

0
vs 0.01

Q1.24

arrow
arrow

+2%

0.02
vs 0

Q2.24

arrow
arrow

+2%

0.02
vs 0.02

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

571

571
vs 561

2%

Q4.22

arrow
arrow

600

600
vs 571

5%

Q1.23

arrow
arrow

585

585
vs 600

-2%

Q2.23

arrow
arrow

588

588
vs 585

1%

Q3.23

arrow
arrow

540

540
vs 588

-8%

Q4.23

arrow
arrow

578

578
vs 540

7%

Q1.24

arrow
arrow

597

597
vs 578

3%

Q2.24

arrow
arrow

583

583
vs 597

-2%

Earnings Growth

Latest News